Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Labeling of human mesenchymal stem cells with different classes of vital stains: robustness and toxicity

Fig. 3

Phenotypical analysis of hBM-MSC in the 2nd and 7th day of culture after staining with CellTracker™ Green CMFDA (CMFDA), eGFP (mRNA GFP), and Molday ION Rhodamine B™ (Molday) with antibodies directed against proteins: CD90, CD44, SSEA4, and CXCR4 performed by cytometric analysis (a, c, e, g). The bar charts (b, d, f, h) show the comparison of the percentage of hBM-MSC positive for particular antigen among control, CellTracker™ Green CMFDA (CMFDA), eGFP (mRNA GFP), and Molday ION Rhodamine B™ (Molday)-stained cell groups. *p < 0.05, **p < 0.01, ***p < 0.001 (n = 3–4)

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512